National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G ↓	Ingredients	Dosage	Form	Price
N05AH04	JOSWE QUZAL 25	G	Quetiapine - 25mg	25mg	Tablet	258,018 L.L
D06BB10	JEDARA	G	Imiquimod - 5%	5%	Cream	3,850,109 L.L
N05AH04	JOSWE QUZAL 25	G	Quetiapine - 25mg	25mg	Tablet	490,503 L.L
M03BX08	JAMP-CYCLOBENZAPRINE	G	Cyclobenzaprine HCl - 10mg	10mg	Tablet	4,031,528 L.L
N05AH04	JOSWE QUZAL 200	G	Quetiapine - 200mg	200mg	Tablet	1,130,172 L.L
N05AH04	JOSWE QUZAL 200	G	Quetiapine - 200mg	200mg	Tablet	2,147,460 L.L
C10AA05	JOSWE ATORVAST 10	G	Atorvastatin - 10mg	10mg	Caplet, film coated	849,308 L.L
N05AH04	JOSWE QUZAL 400	G	Quetiapine - 400mg	400mg	Tablet	2,697,092 L.L
N05AH04	JOSWE QUZAL 400	G	Quetiapine - 400mg	400mg	Tablet	5,124,071 L.L
C10AA05	JOSWE ATORVAST 20	G	Atorvastatin - 20mg	20mg	Caplet, film coated	956,816 L.L
N07AX01	JAMP PILOCARPINE	G	Pilocarpine HCl - 5mg	5mg	Tablet	3,668,690 L.L
J01CR02	JULMENTIN 2X	G	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Powder for suspension	278,175 L.L
R05CA12	JOS-PAN	G	Dried Ivy leaf extract (Hederacoside C) - 75mg/100ml		Syrup	306,396 L.L
J01CR02	JULMENTIN ES	G	Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml	642.9mg/5ml	Powder for suspension	507,972 L.L
N05AX12	JOSWE ARIPAL 10	G	Aripiprazole - 10mg	10mg	Tablet	2,210,621 L.L
C10AA05	JOSWE ATORVAST 40	G	Atorvastatin - 40mg	40mg	Caplet, film coated	1,327,716 L.L
N05AX12	JOSWE ARIPAL 30	G	Aripiprazole - 30mg	30mg	Tablet	4,687,323 L.L
J01CR02	JULMENTIN FORTE	G	Amoxicillin (trihydrate) - 500mg, Clavulanic Acid (potassium) - 125mg	625mg	Tablet, film coated	245,923 L.L
N05AX12	JOSWE ARIPAL 15	G	Aripiprazole - 15mg	15mg	Tablet	2,413,541 L.L
N05AX12	JOSWE ARIPAL 5	G	Aripiprazole - 5mg	5mg	Tablet	1,389,533 L.L
J01CR02	JULMENTIN 2X	G	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Tablet	401,809 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	271,456 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	514,692 L.L
A02BC03	JOSWE LANZOTEC 15	G	Lansoprazole - 15mg	15mg	Capsule	270,112 L.L
M01AB05	JOFLAM	G	Diclofenac potassium - 50mg	50mg	Tablet, film coated	322,522 L.L
M01AB05	JOFLAM	G	Diclofenac potassium - 50mg	50mg	Tablet, film coated	215,015 L.L
B03BA01	JECTIN-12	G	Cyanocobalamin - 1000mcg/1ml	1000mcg/1ml	Injectable solution	567,102 L.L
J01MA12	JOSWE AVOXIN 500	G	Levofloxacin - 500mg	500mg	Tablet, film coated	786,148 L.L
J01MA12	JOSWE AVOXIN 750	G	Levofloxacin - 750mg	750mg	Tablet, film coated	1,550,794 L.L
D11AX11	JOLITE FORTE CREAM	G	Hydroquinone - 4%	4g/100g	Cream	612,792 L.L